A multi-centre, randomized, double-blind, placebo-controlled clinical trial of the efficacy and safety of chloroquine phosphate, hydroxychloroquine sulphate and lopinavir/ritonavir for the treatment of COVID-19 in Lagos State: study protocol for a randomized controlled trial

BACKGROUND: The coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that was first identified in Wuhan, Hubei, China, in December 2019. It was recognized as a pandemic by the World Health Organization on 11 March 2020. Outbreak forecastin...

Descripción completa

Detalles Bibliográficos
Autores principales: Abayomi, A., Osibogun, A., Ezechi, O., Wright, K., Ola, B., Ojo, O., Kuyinu, Y., Zamba, E., Abdur-Razzaq, H., Erinoso, O. A., Anya, S. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642768/
https://www.ncbi.nlm.nih.gov/pubmed/34863267
http://dx.doi.org/10.1186/s13063-021-05675-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642768/
https://www.ncbi.nlm.nih.gov/pubmed/34863267
http://dx.doi.org/10.1186/s13063-021-05675-x

Ejemplares similares